Share on StockTwits

Targacept (NASDAQ:TRGT) saw a large decrease in short interest in August. As of August 15th, there was short interest totalling 823,717 shares, a decrease of 34.0% from the July 31st total of 1,248,234 shares, Stock Ratings Network.com reports. Based on an average trading volume of 263,133 shares, the short-interest ratio is currently 3.1 days. Currently, 2.8% of the company’s stock are sold short.

Several analysts have recently commented on the stock. Analysts at MKM Partners cut their price target on shares of Targacept from $3.50 to $3.00 in a research note on Tuesday, July 29th. They now have a “neutral” rating on the stock.

Targacept (NASDAQ:TRGT) opened at 2.72 on Thursday. Targacept has a 52 week low of $2.68 and a 52 week high of $6.11. The stock’s 50-day moving average is $3.07 and its 200-day moving average is $4.05. The company’s market cap is $91.9 million.

Targacept (NASDAQ:TRGT) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.24) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.33) by $0.09. The company had revenue of $0.04 million for the quarter. During the same quarter in the prior year, the company posted ($0.37) earnings per share. On average, analysts predict that Targacept will post $-1.07 earnings per share for the current fiscal year.

Targacept, Inc is a biopharmaceutical company. The Company is engaged in the design, discovery and development of NNR Therapeutics for the treatment of diseases and disorders of the nervous system.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.